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Aptamers are single-stranded oligonucleotides composed of RNA or DNA that are able to bind their
corresponding targets via molecular recognition. Thus, aptamers can be thought of as nucleic acid-
based alternatives to antibodies and have attracted attention as receptors in biosensors. Aptamers seem
to be ideal biological recognition elements, since they enable the design of intelligent sensors based on
their specific properties. Especially the fact that most aptamers undergo conformational changes during
the binding of the target and their oligonucleotide nature can be used to rationally design novel sensing
strategies. This review focuses on aptasensors for the detection of small molecules. In the first part, ap-
tamers, their generation and their properties are briefly described. In the second part, different design
strategies for aptasensors are reviewed, and examples for the detection of small molecules are given.
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1. Introduction
The sensitive and specific detection of small
molecules remains to be a challenging task. The most
widely used method for the detection and quantifi-
cation of small molecules is high-performance liquid
chromatography (HPLC) with UV and/or fluorescence
detection [1]. These methods have several disadvan-
tages: They are laborious, and the extraction and clean-
up processes of the columns is time-consuming. More
sensitive and specific assays for the rapid detection of
small molecules are needed. Biosensors for the detec-
tion of small analytes have been rapidly developed in
the past decades and seem to satisfy the demands for
timely and sensitive detection. This review focuses on
aptasensors, a special class of biosensors utilizing ap-
tamers as an element for molecular recognition. In the
first part of the review aptamers, their generation and
their properties are briefly described. In the second
part, a review of the literature is given with focuses
on small molecule analytes and the different possible
design strategies for aptasensors.
2. Aptamers
Aptamers are single-stranded oligonucleotides com-
posed of RNA or DNA generated by in vitro selection
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Fig. 1 (color online). Schema-
tic illustration of the genera-
tion of aptamers via system-
atic evolution of ligands by
exponential enrichment (SE-
LEX). Modified from Proske
et al. [8].
techniques (described in Section 2.1). Aptamers are
able to fold into well-defined three-dimensional struc-
tures that enable the binding of a corresponding tar-
get via molecular recognition. Thus, aptamers can be
thought of as a nucleic acid-based alternative to anti-
bodies. Aptamers have already been selected as a probe
for proteins, viruses, cells, as well as small molecules
like vitamins, organic dyes, antibiotics, amino acids,
nucleotides, and peptides [2].
2.1 Selection of aptamers
Aptamers can be generated by an in vitro selec-
tion technique termed systematic evolution of ligands
by exponential enrichment (SELEX) [3 – 5]. During
SELEX, aptamers are isolated from combinational li-
braries of synthetic oligonucleotides with regard to
their affinity towards a given target molecule. There-
fore, in a typical SELEX process (Fig. 1), the tar-
get is immobilized on a solid support like magnetic
beads [6]. The oligonucleotides of the combinational
library consist of a randomized region flanked by
primer binding sites of known sequences. Frequently,
the random region contains 40 nucleotides. Theoreti-
cally, this library can contain 440 individual sequences;
in practice 1014 – 1015 individual sequences can be
found [7]. During the incubation of the library with
the target, a small proportion of the sequences is able
to bind to the target, and non-binding sequences are
removed. The binding sequences are eluted from the
target and amplified by PCR. The resulting pool of en-
riched and amplified binders is employed as starting
material of a subsequent SELEX cycle.
Typically, 8 – 16 SELEX cycles are applied to se-
lect aptamers with appropriate affinity towards the
target. After selection, the final pool of oligonu-
cleotides, which is composed of several aptamers di-
rected against the target, is cloned and sequenced. Fi-
nally, the aptamers can be produced chemically by
solid-phase synthesis.
While SELEX represents an iterative process of se-
lection and amplification, more recently other tech-
niques have been developed to obtain aptamers by
one-step procedures including MonoLEX [9] and non-
equilibrium capillary electrophoresis of equilibrium
mixtures [10].
2.2 Properties of aptamers
Aptamers were shown to have dissociation con-
stants in the nanomolar or even picomolar range and
to bind their target with high specificity. The bind-
ing between the aptamer and the target is based on
hydrogen bonding, hydrophobic and electrostatic in-
teractions and steric effects [11]. In case of a pro-
tein target, the complementarity of the surfaces of tar-
get and aptamer contributes to the binding. In con-
trast, small molecule targets are often bound in a nar-
row binding pocket deep within the structure of the
aptamer.
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Table 1. Differences between antibodies and aptamers and their consequences for the development of aptasensors. Adapted
and extended from Walter et al. [16].
Antibody Aptamer Consequences for aptasensor development
Development depends on
animals, not applicable for all
targets. For haptens, coupling to
a carrier is necessary.
Identification via in vitro
selection techniques, applicable
for virtually all types of targets.
Aptamers can be used as recognition elements for virtually all types
of targets like toxic or non-immunogenic substances including small
molecules.
In vivo production results in high
costs and batch-to-batch
variations.
Chemical synthesis allows more
cost-effective production with
high reproducibility.
Costs of aptasensors can be reduced, high quality ensured by
chemical synthesis.
Modification (e. g. with linkers,
dyes) takes place at random
positions.
During synthesis, modifications
can be introduced at defined
positions.
Controlled modification of aptamers enables controlled immobili-
zation and high activity of immobilized aptamers. Modification with
dyes facilitates the development of biosensors.
Recognize their target under
physiological/close to physiolog-
ical conditions.
Conditions can be adopted in
order to generate aptamers active
under desired conditions.
Aptasensors can be designed with recognition elements functional
under desired assay conditions with no need for sample preparation
Are highly conserved
biomolecules, different
antibodies behave similar.
Are highly diverse in structure
and behavior.
Aptasensors need to be optimized for each individual aptamer.
Are sensitive to temperature,
denaturation is irreversible.
Are stable against temperature,
denaturation is reversible.
Aptasensors can be used in a wide range of assay conditions.
Shelf life is limited; regeneration
may result in a loss of activity.
Long shelf life; regeneration can
be performed without affecting
activity.
Aptasensors are stable for extended periods of time and can be
regenerated.
High molecular weight
(∼ 150 kDa for IgG).
Low molecular weight
(13 – 26 kDa).
Aptamers can be immobilized in high density resulting in a broad
dynamic range of the sensor.
In most cases, aptamers are reported to bind their
targets via adaptive binding [12]. During the approx-
imation of aptamer and target, the aptamer under-
goes conformational reorganization in order to maxi-
mize interactions with the target. These conformational
changes can be used to detect the binding events (fur-
ther described in Section 3.1).
Based on their oligonucleotide nature and their gen-
eration by in vitro selection, aptamers offer some ma-
jor advantages over their amino acid-based counter-
parts (Table 1). While the development of antibodies
depends on the immunization of animals, aptamers
are selected by in vitro techniques. Small molecules
(haptens) are usually non-immunogenic and do not in-
duce an immune response unless coupled with macro-
molecules (carriers) such as proteins [13]. In contrast,
aptamers can be selected for virtually all types of tar-
gets including those with high toxicity or low immuno-
genicity, which qualifies them especially as binders for
small target molecules.
Moreover, as the identification of antibodies is per-
formed under in vivo conditions, the use of antibod-
ies is restricted to conditions similar or close to phys-
iological conditions. For aptamers, the in vitro selec-
tion can be performed under non-physiological con-
ditions in order to generate aptamers that are func-
tional under certain conditions. Thus, in the case of ap-
tamers, a tailor-made affinity ligand can be obtained
that is optimized for a certain application, e. g. an
analytical problem [7]. While the possibility to se-
lect aptamers under varying conditions is advanta-
geous for the detection of the target in its natural
environment (e. g. in environmental and food sam-
ples) it may be problematic for the general design of
aptamer-based assays. Since different aptamers are se-
lected under different conditions, and need these con-
ditions to maintain their functionality, general pro-
cedures for aptamer-based assays are hard to de-
fine. For example, the aptamer’s selection buffer may
be incompatible with the chemistry used to immobi-
lize the aptamers [14]. Moreover, aptamers are very
diverse in their composition (DNA, RNA), length
(25 – 120 nucleotides), and structural features (e. g. G-
quadruplexes, three-dimensional folding). This diver-
sity complicates the transfer of an established aptamer-
based assay from one aptamer to another and necessi-
tates the optimization of the assay for each aptamer. In
contrast, antibodies are highly conserved biomolecules
enabling straightforward transfer of antibody-based
assays.
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Fig. 2 (color online). Schematic illustration of a biosensor.
Once selected and sequenced, aptamers can be pro-
duced by chemical synthesis resulting in high repro-
ducibility. In contrast, the production of antibodies
depends on cell culture techniques, which may be
a source of batch-batch variations. Moreover, during
synthesis of aptamers modifications like linkers can be
introduced at precise positions of the aptamer facili-
tating the immobilization on sensor surfaces or the in-
corporation of reporter groups for detection. Another
major advantage of aptamers is their high stability. As
oligonucleotides, they can undergo denaturation, but in
contrast to antibodies, this denaturation is reversible.
They can be easily regenerated and are stable to long-
term storage. Because of their high affinity and speci-
ficity in combination with substantial advantages over
conventional affinity ligands, aptamers are beginning
to rival antibodies in many techniques based on molec-
ular recognition including their use as affinity elements
in biosensors [7]. The use of aptamers can extend the
use of biosensors to the detection of targets not acces-
sible by antibodies. Besides the obvious advantages of
aptamers, there are some concerns about the stability
of aptamers against nucleases present in biological flu-
ids. This problem can be easily overcome by the use of
nuclease-resistant aptamers, e. g. by post-SELEX mod-
ifications of the aptamer [15].
3. Aptasensors for Small Molecule Detection
Biosensors are able to transform chemical infor-
mation, like the concentration of an analyte, into
a detectable signal. A typical biosensor is composed
of a biological recognition element immobilized on
a transducer (Fig. 2). The transducer converts the bind-
ing event into a signal dependent on the concentra-
tion of the analyte. The recognition component of the
biosensor binds to the analyte by molecular recogni-
tion. Thus, the sensitivity and specificity of the sensor
are driven by the binding properties of this component.
Conventional recognition components include an-
tibodies and enzymes. These protein-based recogni-
tion elements exhibit some disadvantages. E. g., for
a given analytical problem, a suitable enzyme may not
be available. In case of antibodies, there are several an-
alytes against which antibodies are difficult to raise.
This is especially true for toxic and non-immunogenic
targets including many small molecules. Moreover,
proteins like antibodies or enzymes are sensitive to
degradation, which limits the shelf-life and the use of
the biosensor under non-physiological conditions.
More recently, aptamers have been used as recog-
nition elements; these types of biosensors have been
termed “aptasensors” [17, 18]. Aptasensors have al-
ready been described for the detection of small
molecules [19], proteins [20 – 22], and microorgan-
isms [23]. Here, aptamers are used as biological recog-
nition elements and offer several advantages over an-
tibodies (Table 1). Aptamers enable the application of
detection methods usually applied in antibody-based
biosensors including sandwich-based and competitive
assays [24].
Besides this simple substitution of antibodies by
aptamers, aptamers enable the development of com-
pletely new sensor strategies. Especially two features
of aptamers facilitate their use as novel intelligent bio-
logical recognition elements in biosensors:
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1. Most aptamers undergo conformational changes
during target binding. These changes can be ex-
ploited to design sensing strategies.
2. Since aptamers are oligonucleotides, it is possible
to design complementary oligonucleotides that hy-
bridize with the aptamer. Competitive displacement
of these complementary oligonucleotides by the tar-
get can be used to sense target binding.
Based on these general considerations, Han et al. have
classified four different types of aptasensors according
to the used mode of detection [24]:
(i) target-induced structure switching mode (TISS),
(ii) target-induced dissociation mode (TID),
(iii) competitive replacement, and
(iv) sandwich or sandwich-like mode.
In the following paragraphs, we will elucidate the dif-
ferent modes of detection and give examples for corre-
sponding sensors with focus on the detection of small
molecules. The principles of signal generation will be
explained, and some examples are given to illustrate
the underlying mechanisms. A more comprehensive
overview of the current literature is given in Table 2.
3.1 Aptasensors based on target-induced structure
switching
According to the induced fit mechanism, the bind-
ing of the target results in conformational changes of
the aptamer. In the target-induced structure switch-
ing (TISS) mode, these conformational changes are
used to generate a detectable signal [24]. The TISS
strategy has been widely used in electrochemical ap-
tasensors (Fig. 3). Here, the aptamers are covalently
attached to an electrode surface via one of the aptamer
termini, while the other terminus is modified with an
electrochemically active redox compound like methy-
lene blue or ferrocene. In the absence of the target,
the redox compound is positioned far away from the
surface resulting in no detectable signal. In the pres-
ence of the target, the aptamer adopts a folded con-
formation and the distance between the redox com-
pound and the electrode surface decreases resulting
in an electrochemical signal. Within this sensor con-
cept, the electrochemical signal increases with increas-
ing concentration of target (signal-on sensor). Since
many aptamers contain partially folded structural el-
ements even in the absence of the target, the TISS ap-
proach may not lead to sufficient signal intensities for
Fig. 3 (color online). Aptamer-based electrochemical sensing
involving target-induced structure switching (TISS) of the
aptamer. Modified from Willner and Zayats [28].
all native aptamers. Therefore, White et al. have inves-
tigated different methods to enhance the target-induced
structural changes. Here, the destabilization of the na-
tive aptamer folding (in the absence of the target) re-
sults in signal enhancement and allows the detection
of ATP [25].
One other example for the TISS mode is the so-
called aptamer beacon [26]. Here one of the ap-
tamer’s termini is covalently modified with a fluo-
rophore while the other terminus is modified with
a quencher molecule. When fluorophor and quencher
are in close proximity to each other, the signal emit-
ted by the fluorophore is quenched. Stojanovic et al.
have constructed an aptamer beacon based on an ap-
tamer directed against cocaine. In the absence of co-
caine, the fluorophore and the quencher were distant to
each other. The binding of cocaine induces a structural
rearrangement of the aptamer including the formation
of a stem formed by the termini of the aptamer. Thus,
the quencher could quench the fluorescence in the pres-
ence of the target, resulting in a signal-off sensor for
cocaine [27].
3.2 Aptasensors based on target-induced dissociation
In the target-induced dissociation or displacement
(TID) mode [24], aptamers are immobilized on the
sensors’ surface. Oligonucleotides complementary to
the aptamers sequence bind to the aptamer via hy-
bridization to form a duplex. In the presence of the tar-
get, the aptamer forms a complex with the target, and
the complementary oligonucleotide dissociates from
the immobilized duplex. For example, this dissocia-
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Table 2. Aptasensors for the detection of small molecules. TISS: target-induced structure switching, TID: target-induced
dissociation, TIR: target-induced reassembly of aptamer fragments.
Design
strategy
Mode of detection Target LOD Dynamic
range
Sample Comments Reference
TISS Electrochemical Cocaine Undiluted
fetal calf
serum, undi-
luted blood
Regeneration of sen-
sor by washing with
serum lacking cocaine
Swensen
et al.
(2009) [47]
TISS Electrochemical ATP 25 – 250000 µM Tris buffer Reagentless sensor White et al.
(2010) [25]
TISS Optical
(colorimetric)
Adenosine 20 – 2000 µM Based on stabiliza-
tion of AuNPs by
folded aptamer target
complexes
Zhao et al.
(2008) [48]
TISS Electrochemical Cocaine 0.3 µM 1 – 150 µM Phosphate-
buffered
saline, di-
luted serum
Regeneration of sensor
by heat denaturation
Hua et al.
(2010) [33]
TISS Optical
(colorimetric)
Oxytetra-
cycline
0.025 µM 0.025 – 1 µM
(linear range)
Tris buffer Aggregation of AuNPs
leading to color change
Kim et al.
(2010) [49]
TISS Electrochemical Cocaine < 10 µM,
500 µM (in diluted
fetal calf serum,
human saliva)
Diluted fetal
calf serum,
human saliva
Regeneration via a brief
washing at r. t.
Baker et al.
(2006) [50]
TISS Optical
(electrochemi-
luminescence)
ATP 0.006 µM 0.018 – 90.72 µM Phosphate
buffered
saline
Huang et al.
(2010) [51]
TISS Electrochemical Cocaine 0.5 µM 1 – 15 µM Phosphate-
buffered
saline
Regeneration with Tris
buffer
Li et al.
(2008) [52]
TISS Electrochemical Tetra-
cycline
0.01 µM 0.01 – 10 µM Tris buffer Kim et al.
(2010) [53]
TISS Optical
(fluorescence)
Cocaine 12.5 – 1500 µM Tris buffer,
human
serum
Signalling aptamer/
aptamer beacon
Stojanovic
et al.
(2001) [27]
TID Electrochemical ATP 0.01 µM 0.01 – 1000 µM Lysed cells Zuo et al.
(2007) [30]
TID Optical (chemi-
luminescence)
Cocaine 0.00048 µM 0.001 – 0.01 µM
(linear range)
Phosphate-
buffered
saline
Li et al.
(2011) [32]
TID Electrochemical Adenosine 0.00002 µM 0.00002 – 0.02 µM Tris buffer Bifunctional sensor for
adenosine and lysozyme
Deng et al.
(2009) [54]
TID Electrochemical Adenosine 0.000002 µM Zayats et al.
(2006) [55]
TID Chronocoulo-
metric
Adenosine
monophos-
phate
0.1 µM 0.1 – 1000 µM Shen et al.
(2007) [56]
TID Electrochemical ATP 0.01 – 0.08 µM
(linear range)
Tris buffer Regeneration by heat
denaturation
Lu et al.
(2008) [57]
TID Electrochemical Adenosine 1 µM 1 – 1000 µM Regeneration by rehy-
bridizing ATP-binding
aptamer with comple-
mentary strand
Li et al.
(2007) [58]
TID Electrochemical Adenosine 0.001 µM
(estimated)
0.005 – 1 µM
(linear regression
curve)
Regeneration by im-
mersing the electrode
in adenosine aptamer
solution
Feng et al.
(2008) [59]
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Table 2. (Continued.)
Design
strategy
Mode of detection Target LOD Dynamic
range
Sample Comments Reference
TID Electrochemical Adenosine 0.01 µM 0.01 – 2 µM Phosphate-
buffered
saline
Regeneration by hy-
bridizing the aptamer
with complementary
oligonucleotide
Wang et al.
(2009) [60]
TID Optical
(colorimetric)
Adenosine,
Cocaine
20 µM
(Adenosine)
10 µM
(Cocaine)
Tris-acetate buffer,
untreated human
blood serum
(cocaine)
Lateral flow
technology,
“dipsticks”
Liu et al.
(2006) [61]
TID Optical
(interferometry)
ATP 400 µM 400 – 1500 µM Tris buffer Carrasquilla
et al. (2011)
[29]
TID Electrochemical ATP 0.0001 µM 0.0001 – 0.1 µM Tris buffer Du et al.
(2009) [62]
TID Optical (SPR
spectroscopy)
Adenosine 0.00001 – 0.1 µM Tris buffer Wang et al.
(2009) [63]
TID Optical (surface-
enhanced Raman
scattering)
Adenosine 0.01 µM 0.02 – 2 µM Phosphate-
buffered
saline
Regeneration by
heat denaturation
Chen et al.
(2008) [64]
TID Electrochemical ATP 0.01 µM 0.01 – 100 µM Parallel detection of
ATP and α-thrombin
Du et al.
(2008) [65]
TID Optical (flow
cytometry)
Adenosine 178 µM
(in buffer)
167 µM (in
30% serum)
HEPES buffer,
diluted human
blood serum
Huang et al.
(2010) [66]
Competitive
replacement
Impedimetric
(Faradaic
impedance
spectroscopy)
Neomycin B 0.75 – 500 µM
(in buffer)
25 – 2500 µM
(in diluted milk)
Tris buffer,
diluted milk
Regeneration with
highly concentrated
saline solution,
neomycin B solution
de-los-San-
tos- ´Alvarez
(2007) [34]
Sandwich Electrochemical Sodium
diclofenac
0.27 µM 0 – 5 µM
10 – 1000 µM
(two different
linear ranges)
Human blood
serum
Kashefi-
Kheyrabadi
(2012) [67]
Sandwich Optical (light
scattering)
Oxytetra-
cycline
100 ppb 100 – 104 ppb Phosphate-buffered
saline
Kim et al.
(2010) [68]
TIR Electrochemical Cocaine 0.1 µM 0.1 – 38.8 µM Tris buffer, human
plasma, serum,
saliva, urine
Du et al.
(2010) [69]
TIR Optical
(fluorescence)
Cocaine
ATP
0.1 µM
(Cocaine)
0.2 µM
(ATP)
0.5 – 1000 µM (lin-
ear range, cocaine)
1 – 1000 µM
(linear range, ATP)
Phosphate buffer Zhou et al.
(2011) [40]
TIR Optical
(colorimetric)
Adenosine
Cocaine
250 µM
(Adenosine)
100 µM
(Cocaine)
250 – 1000 µM Tris buffer Li et al.
(2009) [39]
TISS Optical
(colorimetric)
ATP,
Cocaine
5 µM HEPES buffer Aptamer-DNAzyme
cascade
Elbaz et al.
(2009) [70]
tion can be detected optically by modification of the
aptamer with a fluorophore and the complementary
oligonucleotide with a quencher (Fig. 4). For regener-
ation of the TID-based sensor, the aptamer-modified
sensor can be re-incubated with the complementary
oligonucleotide [29].
This duplex-to-aptamer approach has been used for
electrochemical detection of ATP by Zuo et al. Here,
the ferrocene-modified aptamer was immobilized on
the gold surface of the sensor and hybridized with
a complementary oligonucleotide to form a duplex.
Due to the rigid structure of the duplex, the “off”
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Fig. 4 (color online). Aptamer-based optical sensing involv-
ing target-induced dissociation (TID) of a complementary
oligonucleotide from the aptamer. Modified from Tuleuova
et al. [31].
state of the sensor is well-defined with the ferrocene
positioned far away from the sensor surface (approx.
10 nm). In the presence of ATP the aptamer forms
a complex with the target, and the complementary
oligonucleotide is released from the duplex. Within the
aptamer-target complex, the ferrocene comes into close
proximity to the sensor surface in the “on” state of the
sensor resulting in an electrochemical signal [30].
Li et al. have used TID to create a chemilumines-
cence sensor for cocaine detection. Here, the aptamer
is immobilized on magnetic beads. A complementary
oligonucleotide was immobilized on gold nanoparti-
cles, which were also modified with horseradish perox-
idase. In the absence of cocaine, a duplex is formed by
the aptamer and the complementary oligonucleotide,
and the addition of cocaine induces the release of
the double-functional gold nanoparticles. After mag-
netic separation, the liberated gold nanoparticles were
incubated with luminol, p-iodophenol and H2O2 re-
sulting in the detection of a chemiluminescence sig-
nal. This sensor shows very good sensitivity (LOD
480 pM) which has been assumed to be a result of
the gold nanoparticle loading with several peroxidase
molecules [32].
3.3 Aptasensors based on competitive replacement
In aptasensors based on competitive replace-
ment [33], the aptamer is immobilized on the sensor
surface. Before the measurement of the analyte, the la-
belled target is bound to the aptamer. Non-labelled tar-
Fig. 5 (color online). Aptamer-based electrochemical sensing
involving competitive replacement of the aptamer from the
immobilized target. Modified from de-los-Santos-Alvarez et
al. [34].
get molecules present in the sample competively bind
to the aptamer resulting in a displacement of bound
target. It is also possible to immobilize the target on
the surface and bind the aptamer to the immobilized
target (Fig. 5). In the context of small molecule detec-
tion, this approach has been used to detect neomycin B.
Neomycin B was immobilized on the sensor surface,
and an aptamer directed against neomycin was bound
to the immobilized target. The presence of neomycin
in the sample resulted in the competitive binding of
the free neomycin to the aptamer and a release of
the aptamer from the immobilized target which could
be detected by Faradaic impedance spectroscopy or
SPR [34, 35].
3.4 Aptasensors of sandwich-type
Within the sandwich mode, one aptamer directed
against the target is immobilized on the sensors sur-
face. The target binds to this immobilized aptamer, and
detection is performed by binding of a second aptamer
(Fig. 6). Therefore, the target has to contain at least two
distinct binding sites for aptamers. While the sandwich
mode is widely applied to protein detection [36 – 38],
it is limited for small molecule detection. In case of
aptamers directed against small molecules, the target
is often completely embedded into the aptamers struc-
ture. Thus, the bound target provides no more space for
the binding of a second aptamer.
Nonetheless, White et al. have designed an elec-
trochemical “pseudo-sandwich” aptamer-based sensor
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Fig. 6 (color online). Aptamer-based electrochemical sensing
based on sandwich-like binding of two aptamers to one target
molecule. Modified from Willner and Zayats [28].
for the detection of ATP by separating the aptamer di-
rected against ATP into two parts utilizing an inter-
nal polythymine linker. Here, the binding of the tar-
get induces the association of the separated domains
of the aptamer [25]. Consequently, in the classifica-
tion according to Han et al. [24], this sensor rather be-
longs to the TISS mode than to real sandwich mode
sensors.
3.5 Aptasensors based on target-induced reassembly
of aptamer fragments
In addition to the four sensor concepts described by
Han et al. [24], we have identified a novel sensor prin-
ciple based on the unique structural properties of ap-
tamers. This design is based on the target-induced re-
arrangement of aptamer fragments (TIR, Fig. 7).
Fig. 7 (color online). Aptamer-based optical sensing based
on target-induced reassembly of aptamer fragments (TIR).
Modified from Li et al. [39].
Here, the aptamer is divided into two parts that do
not interact with each other in the absence of the tar-
get. In the presence of the target, the two fragments re-
assemble to form a three-molecular complex with the
target. This method was employed, for example, by
Zhou et al. to design an aptasensor for the detection
of cocaine. Here, the reassembly of the aptamer frag-
ments was detected by modifying the fragments with
silver nanoclusters (NC), which show an increase in
fluorescence at decreasing distances of Ag NCs [40].
4. Current Limitations and Future Perspectives
As elaborated above, aptasensors can be designed
in different formats to enable the detection of small
molecules using different techniques for sensing.
Nonetheless, the summary of the literature given in Ta-
ble 2 reveals that aptasensors have been used only for
the detection of few small molecules yet. Most of the
aptasensors described in the literature were used for
the detection of adenosine, ATP, and cocaine, and only
few reports on other analytes were found.
Since plenty of aptamers directed against diverse
small molecules have already been published [41, 42],
this restriction of aptasensors to mainly three analytes
is quite surprising. Within the young and further de-
veloping field of aptasensors, many researchers have
focused on the well-characterized aptamers directed
against ATP and cocaine for the development of ap-
tasensors, and other targets will likely follow in the
near future.
Another concern that may arise regarding aptamers
is their relatively costly production. In this context, we
expect the prices of oligonucleotides to decrease. This
process is further driven by the development of phar-
maceutical oligonucleotides. The first aptamer-based
therapeutic (Pegaptanib) has been approved in 2004 for
the treatment of age-related macular degeneration [43],
and in 2009 the number of oligonucleotide thera-
peutic programs has increased to 231 [44, 45]. This
progress accelerates the development of more eco-
nomic methods for the large-scale synthesis of high-
quality oligonucleotides [46].
5. Summary and Conclusion
It has been demonstrated that aptasensors can be
used for the sensitive and specific detection of small
molecules even in complex samples. Many different
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formats with varying read-out techniques have already
been applied successfully. Aptamers seem to be ideal
biological recognition elements for the design of in-
telligent sensors based on their specific properties. Es-
pecially the fact that most aptamers undergo confor-
mational changes during the binding of the target is
a basis for novel sensor strategies. Moreover, due to
their oligonucleotide nature, it is possible to rationally
design novel sensing strategies involving oligonu-
cleotides complementary to the aptamers sequence.
Based on these outstanding advantages of aptamer-
based biosensing, the use of aptasensors, which is yet
limited to only few targets, will likely expand to the
detection of further targets within the near future.
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